ANTHERA PHARMACEUTICALS INC's ticker is ANTH and the CUSIP is 03674U201. A total of 74 filers reported holding ANTHERA PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 19.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2016 | $459,000 | +2.0% | 145,622 | 0.0% | 0.08% | -3.8% |
Q2 2016 | $450,000 | +75.8% | 145,622 | +106.2% | 0.08% | +56.0% |
Q1 2016 | $256,000 | -83.3% | 70,622 | -60.2% | 0.05% | -87.8% |
Q2 2015 | $1,530,000 | +188.7% | 177,500 | +49.8% | 0.41% | +165.6% |
Q1 2015 | $530,000 | – | 118,500 | – | 0.15% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ProQuest Associates IV LLC | 1,900,000 | $16,378,000 | 3.36% |
Hilltop Park Associates LLC | 120,000 | $1,034,000 | 2.05% |
Abingworth LLP | 437,994 | $3,767,000 | 1.71% |
Sio Capital Management, LLC | 238,158 | $2,053,000 | 1.01% |
Rhenman & Partners Asset Management AB | 619,600 | $5,341,000 | 0.64% |
Broadfin Capital, LLC | 1,370,457 | $11,813,000 | 0.64% |
Perceptive Advisors | 1,202,156 | $10,363,000 | 0.62% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 931,257 | $8,027,000 | 0.60% |
WEXFORD CAPITAL LP | 177,500 | $1,530,000 | 0.41% |
Rock Springs Capital Management LP | 470,000 | $4,051,000 | 0.30% |